These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 6260657

  • 21. Monoclonal antibodies directed against a 130K glycoprotein of bovine herpesvirus 2 cross-react with glycoprotein B of herpes simplex virus.
    Conraths FJ, Pauli G, Ludwig H.
    Virus Res; 1988 Apr; 10(1):53-63. PubMed ID: 2837013
    [Abstract] [Full Text] [Related]

  • 22. Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions.
    Para MF, Parish ML, Noble AG, Spear PG.
    J Virol; 1985 Aug; 55(2):483-8. PubMed ID: 2991571
    [Abstract] [Full Text] [Related]

  • 23. Neutralizing antibody to herpes simplex virus by a novel neutralization method with peroxidase-labelled complement Clq.
    Taguchi F, Kawasaki T, Matsuzaki T, Lee SM.
    J Virol Methods; 1991 May; 32(2-3):157-62. PubMed ID: 1651947
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.
    Glorioso J, Kees U, Kümel G, Kirchner H, Krammer PH.
    J Immunol; 1985 Jul; 135(1):575-82. PubMed ID: 2582051
    [Abstract] [Full Text] [Related]

  • 26. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M, Zarling JM.
    J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus.
    Forrester AJ, Sullivan V, Simmons A, Blacklaws BA, Smith GL, Nash AA, Minson AC.
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():369-75. PubMed ID: 1704412
    [Abstract] [Full Text] [Related]

  • 29. Complement-mediated cytolysis of HSV-1 and HSV-2 infected cells: plasma membrane antigens reactive with type-specific and cross-reactive antibody.
    Glorioso JC, Wilson LA, Fenger TW, Smith JW.
    J Gen Virol; 1978 Aug; 40(2):443-54. PubMed ID: 211189
    [Abstract] [Full Text] [Related]

  • 30. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2.
    McDermott MR, Brais LJ, Evelegh MJ.
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1497-504. PubMed ID: 2165134
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection.
    Kahlon J, Lakeman FD, Ackermann M, Whitley RJ.
    J Clin Microbiol; 1986 Apr; 23(4):725-30. PubMed ID: 2422204
    [Abstract] [Full Text] [Related]

  • 34. Herpes simplex virus-specific hybridoma cells cannot be persistently infected with this virus.
    Eis-Hübinger AM, Friedrich A, Schneweis KE.
    Intervirology; 1992 Apr; 34(1):13-22. PubMed ID: 1330972
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The use of monoclonal antibodies in (reverse) passive haemagglutination tests for herpes simplex virus antigens and antibodies.
    Cranage MP, McLean CS, Buckmaster EA, Minson AC, Wildy P, Coombs RR.
    J Med Virol; 1983 Apr; 11(4):295-306. PubMed ID: 6308140
    [Abstract] [Full Text] [Related]

  • 37. Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses.
    Schmidt NJ, Gallo D.
    J Med Virol; 1984 Apr; 13(1):1-12. PubMed ID: 6319583
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies.
    Lee FK, Pereira L, Griffin C, Reid E, Nahmias A.
    J Virol Methods; 1986 Sep; 14(2):111-8. PubMed ID: 3021801
    [Abstract] [Full Text] [Related]

  • 40. Detection of antibody-secreting cells specific for the cytomegalovirus and herpes simplex virus surface antigens.
    Alt M, Falk J, Eis-Hübinger AM, Kropff B, Sinzger C, Krawczyk A.
    J Immunol Methods; 2018 Nov; 462():13-22. PubMed ID: 30056033
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.